During the recent session, Neuronetics Inc (NASDAQ:STIM)’s traded shares were 0.6 million, with the beta value of the company hitting 1.88. At the last check today, the stock’s price was $5.49, reflecting an intraday gain of 1.29% or $0.07. The 52-week high for the STIM share is $5.92, that puts it down -7.83 from that peak though still a striking 90.53% gain since the share price plummeted to a 52-week low of $0.52. The company’s market capitalization is $219.98M, and the average trade volume was 1.34 million shares over the past three months.
Neuronetics Inc (STIM) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.50. STIM has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.12.
Neuronetics Inc (NASDAQ:STIM) trade information
Neuronetics Inc (STIM) registered a 1.29% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.29% in intraday trading to $5.49, hitting a weekly high. The stock’s 5-day price performance is 28.27%, and it has moved by 59.13% in 30 days. Based on these gigs, the overall price performance for the year is 96.77%.
The consensus price target of analysts on Wall Street is $8, which implies an increase of 31.37% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8 and $8 respectively. As a result, STIM is trading at a discount of -45.72% off the target high and -45.72% off the low.
Neuronetics Inc (STIM) estimates and forecasts
In the rating firms’ projections, revenue will increase 99.43% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 29.07M as predicted by 4 analyst(s). Meanwhile, a consensus of 4 analyst(s) estimates revenue growth to 36.69M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 17.42M and 16.45M respectively. In this case, analysts expect current quarter sales to grow by 66.89% and then jump by 123.05% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 2.87%. While earnings are projected to return 77.06% in 2025, the next five years will return 61.20% per annum.
STIM Dividends
Neuronetics Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Neuronetics Inc (NASDAQ:STIM)’s Major holders
The next largest institutional holding, with 2.38 million shares, is of CANNELL CAPITAL LLC’s that is approximately 7.9239% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $4.29 million.
Also, the Mutual Funds coming in first place with the largest holdings of Neuronetics Inc (STIM) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 849.5 shares. This amounts to just over 2.80 percent of the company’s overall shares, with a $4.68 million market value. The same data shows that the other fund manager holds slightly less at 403.88, or about 1.33% of the stock, which is worth about $2.23 million.
